Domtar Corporation (NYSE:UFS) shares advanced 1.48% in last trading session and ended the day at $41.85. UFS Gross Margin is 20.80% and its has a return on assets of 2.60%. Domtar Corporation (NYSE:UFS) quarterly performance is 7.61%.
Domtar Corporation (NYSE:UFS) announced that its Board of Directors has declared a quarterly dividend on its common stock (UFS) (UFS). The dividend of US$0.40 per share is payable on January 15, 2016 to stockholders of record on January 4, 2016.
Cameron International Corporation (NYSE:CAM) ended the last trading day at $68.52. Company weekly volatility is calculated as 2.02% and price to cash ratio as 6.72. Cameron International Corporation (NYSE:CAM) showed a weekly performance of -3.06%.
Cameron International Corporation (NYSE:CAM) announced that its board of directors has established a record date and a meeting date for a special meeting of stockholders to approve the previously announced proposed acquisition of Cameron by Schlumberger in a stock and cash transaction. Cameron stockholders of record at the close of business on November 16, 2015, will be entitled to notice of the special meeting and to vote upon the proposed transaction at the meeting. The special meeting is scheduled to be held on December 17, 2015.
On 10 November, SunTrust Banks, Inc. (NYSE:STI) shares advanced 1.20% and was closed at $43.75. STI EPS growth in last 5 year was 23.00%. SunTrust Banks, Inc. (NYSE:STI) year to date (YTD) performance is 6.17%.
SunTrust Banks (NYSE: STI) declared a quarterly dividend of $0.24 per share, or $0.96 annualized. The dividend will be payable on December 15, 2015, to stockholders of record on November 30, 2015, with an ex-dividend date of November 25, 2015.
Aratana Therapeutics, Inc. (NASDAQ:PETX) shares fell -11.20% in last trading session and ended the day at $6.74. PETX Gross Margin is 11.10% and its has a return on assets of -18.40%. Aratana Therapeutics, Inc. (NASDAQ:PETX) quarterly performance is -63.01%.
On 5 November, Aratana Therapeutics, Inc. (NASDAQ:PETX), announced its third quarter 2015 financial and operational results. For the quarter ended September 30, 2015, Aratana reported a net loss of $54.4 million or $1.58 basic loss per share. Results included a non-cash asset impairment charge of $43.4 million or $1.26 per share.
Horizon Pharma plc (NASDAQ:HZNP) caters to the Healthcare space. It has a net profit margin of -3.70% and weekly performance is 30.88%. On the last day of trading company shares ended up at $22.38. Horizon Pharma plc (NASDAQ:HZNP) distance from 50-day simple moving average (SMA50) is 8.10%.
Horizon Pharma plc (NASDAQ: HZNP), hosted an investor meeting where for the first time it is providing full-year 2016 net sales and adjusted EBITDA guidance and outlining its long-range plan for its current portfolio of medicines.